Northwestern Mutual Wealth Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.58K	Hold	1,575	–	–	﹤0.01%	3220
2026 Q1	$5.36K	Sell	1,575 -131	-8%	-$444	﹤0.01%	3288
2025 Q4	$4.86K	Buy	1,706 +131	+8%	+$338	﹤0.01%	3238
2025 Q3	$4.16K	Hold	1,575	–	–	﹤0.01%	3202
2025 Q2	$3.54K	Hold	1,575	–	–	﹤0.01%	3110
2025 Q1	$3.37K	Hold	1,575	–	–	﹤0.01%	3037
2024 Q4	$3.81K	Hold	1,575	–	–	﹤0.01%	3020
2024 Q3	$3.84K	Hold	1,575	–	–	﹤0.01%	2973
2024 Q2	$4.05K	Hold	1,575	–	–	﹤0.01%	2921
2024 Q1	$4.6K	Hold	1,575	–	–	﹤0.01%	2866
2023 Q4	$3.64K	Hold	1,575	–	–	﹤0.01%	2952
2023 Q3	$4.11K	Hold	1,575	–	–	﹤0.01%	2803
2023 Q2	$5.64K	Hold	1,575	–	–	﹤0.01%	2744
2023 Q1	$3.43K	Hold	1,575	–	–	﹤0.01%	2848
2022 Q4	$18.9K	Hold	1,575	–	–	﹤0.01%	2268
2022 Q3	$10K	Buy	+1,575	New	+$12.7K	﹤0.01%	2472
2015 Q2	–	Sell	-1,667	Closed	-$11K	–	1567
2015 Q1	$11K	Buy	+1,667	New	+$8.05K	﹤0.01%	1015
2014 Q2	–	Sell	-42	Closed	–	–	1357
2014 Q1	$0	Buy	+42	New	+$709	﹤0.01%	1409

Other funds holding ORMP

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northwestern Mutual Wealth Management's ORMP Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Oramed Pharmaceuticals (ORMP) position steady in Q2 2026 at 1,575 shares worth $7.58K. The position accounts for ﹤0.01% of the portfolio, ranked #3220.

Northwestern Mutual Wealth Management first reported a position in ORMP in Q1 2014 and has held it in 18 quarters since. The position peaked at $18.9K in Q4 2022. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

Northwestern Mutual Wealth Management held 1,575 shares of Oramed Pharmaceuticals worth $7.58K as of Q2 2026.
Northwestern Mutual Wealth Management left its Oramed Pharmaceuticals share count unchanged in Q2 2026.
Oramed Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3220 holding.
Northwestern Mutual Wealth Management first reported a position in Oramed Pharmaceuticals in Q1 2014 and has held it in 18 quarters since.
Northwestern Mutual Wealth Management's Oramed Pharmaceuticals position peaked at $18.9K in Q4 2022.
84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.